Jin-Feng Pan

发表

Pathological characteristics and predictive factors of prostate biopsy in patients with serum PSA levels between 0 and 4.0 ng/ml

Qi Ma, Junhui Jiang, Rui Su, 2022, Frontiers in Oncology.

OTT_A_297603 2797..2803

Jin-Feng Pan, Jian-Zhou Cao, D. Ng, 2021 .

Acute pulmonary embolism and severe post thrombolysis renal bleeding, two deadly complications following mini-percutaneous nephrolithotomy: a rare case report

Yue Cheng, Jin-Feng Pan, Feng-Qi Wang, 2022, BMC Surgery.

Feasibilities and outcomes of patients treated with simultaneous prostate biopsy and general urological surgeries.

Qi Ma, Junhui Jiang, Rui Su, 2022, Experimental and therapeutic medicine.

Medical evaluation and pharmacotherapeutical strategies in management of urolithiasis

Yue Cheng, D. Ng, Maria Haleem, 2021, Therapeutic advances in urology.

Case Report: Anlotinib Combined With Sintilimab as Third-Line Treatment in a Metastatic Urothelial Bladder Carcinoma Patient With FGFR3 Mutation

Hongwei Wang, Qi Ma, Junhui Jiang, 2021, Frontiers in Oncology.

Modified Predictive Model and Nomogram by Incorporating Prebiopsy Biparametric Magnetic Resonance Imaging With Clinical Indicators for Prostate Biopsy Decision Making

Zhen-ya Zhao, Qi Ma, Junhui Jiang, 2021, Frontiers in Oncology.

The Use of High-Intensity Focused Ultrasound (HIFU) Plus 150mg Bicalutamide as First Line Salvage Therapy for Local Recurrent Prostate Cancer

Qi Ma, Rui Su, Jin-Feng Pan, 2021, Frontiers in Oncology.

Case report: Complete response of a bladder cancer patient with multiple hepatic and pelvic metastases treated by nab-paclitaxel combined with sintilimab

Wei Wu, Qi Ma, L. Fang, 2022, Frontiers in Oncology.

Maintenance Long-Term Multiple Cycles Treatment with Docetaxel in Metastatic Castration-Resistant Prostate Cancer: A Report of Three Cases

Qi Ma, Junhui Jiang, Jin-Feng Pan, 2021, OncoTargets and therapy.